@article{936e7970c3494ed8a63f125ebe782a52,
title = "Scientists on the spot: Relaxing the heart in hypertrophic cardiomyopathy",
keywords = "Genetic heart disease, HFpEF, HoCM, Hypertrophic cardiomyopathy, Myosin inhibitor",
author = "Gladka, {Monika M.} and {van der Velden}, Jolanda",
note = "Funding Information: Biography: Dr Monika Gladka is currently an Assistant Professor at University Medical Center in Amsterdam. Her current research focuses on understanding the molecular mechanisms that regulate cardiac repair, intending to identify new players to develop novel, improved gene therapies. She uses several state-of-the-art techniques such as single-cell sequencing, enabling an in-depth mechanistic understanding of the biological processes in injured cardiomyocytes. In 2016 and 2020, she received two prestigious Dr E. Dekker personal grants from the Dutch Heart Foundation for heart repair research. She is actively involved in several cardiac societies acting as a board member of Young@Heart from the Netherlands Heart Institute and a nucleus member of the Scientists of Tomorrow from the European Society of Cardiology.",
year = "2023",
month = may,
day = "1",
doi = "https://doi.org/10.1093/cvr/cvad049",
language = "English",
volume = "119",
pages = "E131--E132",
journal = "Cardiovascular research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "5",
}